Functional improvements in pain and strength have been sustained for 12–36 months in retrospective follow-up studies, though formal long-term tracking is sparse. Reinjury rates are not well quantified; anecdotal evidence suggests some athletes experience recurrent symptoms 2–3 years after treatment, possibly reflecting incomplete tissue remodelling or inadequate rehabilitation.
Tendons are specialised collagenous tissues that transmit muscle force to bone with minimal elasticity—a design that makes them prone to partial tears and degeneration when overstressed. Unlike muscle, tendons have poor intrinsic healing capacity due to limited blood supply and sparse resident cell populations. Recovery from tendon injury often stalls at a fibrotic scar that is weaker and less organised than native tissue. Cell therapy approaches employ placental MSCs, exosomes (acellular vesicles carrying molecular signals), and sometimes engineered chondrocytes to promote tissue remodelling and fibril alignment. The proposed mechanism involves delivering cells or their secreted factors directly to the injury site, where they are thought to reduce inflammation, promote angiogenesis (new blood vessel formation), and guide collagen deposition along physiologically correct orientations.
Bin ich ein Kandidat? → · Tendon & Sports Injuries: full overview → · Sehnen- und Sportverletzungen Kosten → · Cost →
Medizinisch geprüft vom Redaktionsteam von StemCellAtlas zusammen mit Dr Tymur Lukyanenko (Orthopaedic Traumatologist · 20+ yrs clinical, 15+ yrs cell therapy) der Partnerklinik Stem Plus (Sofia), gemäß ISSCR-, FDA- und EMA-Leitlinien. Educational information, not medical advice; figures indicative.
GMP-zertifizierte regenerative Medizin mitten in der EU — ab 3.000–8.000 €, ein Bruchteil der US- oder Deutschland-Preise. Individuelle Protokolle für internationale Patienten aus über 50 Ländern.
Kostenlose ärztliche Prüfung